Copyright
©The Author(s) 2025.
World J Diabetes. Jul 15, 2025; 16(7): 108344
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.108344
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.108344
Table 2 Baseline characteristics of study population by diabetes mellitus duration
Variables | New onset (n = 722231) | < 5 years (n = 677037) | 5-9 years (n = 489945) | ≥ 10 years (n = 605818) | P value |
Age | 53.72 ± 12.36 | 58.75 ± 11.32 | 62.09 ± 10.54 | 65.53 ± 9.77 | < 0.0001 |
Age group | < 0.0001 | ||||
< 40 | 85092 (11.78) | 26721 (3.95) | 6488 (1.32) | 2785 (0.46) | |
40-64 | 504540 (69.86) | 446861 (66) | 286658 (58.51) | 276013 (45.56) | |
≥ 65 | 132599 (18.36) | 203455 (30.05) | 196799 (40.17) | 327020 (53.98) | |
Sex male (%) | 501523 (69.44) | 388124 (57.33) | 277851 (56.71) | 334537 (55.22) | < 0.0001 |
Low income1 | 149558 (20.71) | 148265 (21.9) | 111167 (22.69) | 127377 (21.03) | < 0.0001 |
Smoking | < 0.0001 | ||||
Never | 337007 (46.66) | 377005 (55.68) | 283606 (57.89) | 374969 (61.89) | |
Ex- | 163967 (22.7) | 150191 (22.18) | 110089 (22.47) | 135312 (22.34) | |
Current | 221257 (30.64) | 149841 (22.13) | 96250 (19.65) | 95537 (15.77) | |
Drinking | < 0.0001 | ||||
None | 306986 (42.51) | 404179 (59.7) | 309644 (63.2) | 418953 (69.15) | |
Moderate | 318767 (44.14) | 214381 (31.66) | 143223 (29.23) | 151551 (25.02) | |
Heavy2 | 96478 (13.36) | 58477 (8.64) | 37078 (7.57) | 35314 (5.83) | |
Regular exercise | 147260 (20.39) | 141581 (20.91) | 109065 (22.26) | 143596 (23.7) | < 0.0001 |
Hypertension | 318886 (44.15) | 396558 (58.57) | 316466 (64.59) | 412931 (68.16) | < 0.0001 |
Dyslipidemia | 258643 (35.81) | 447804 (66.14) | 322958 (65.92) | 398651 (65.8) | < 0.0001 |
CKD3 | 33398 (4.62) | 45686 (6.75) | 51080 (10.43) | 109646 (18.1) | < 0.0001 |
Proteinuria | 38161 (5.28) | 37292 (5.51) | 31993 (6.53) | 63237 (10.44) | < 0.0001 |
SBP (mmHg) | 129.44 ± 15.27 | 127.7 ± 14.66 | 127.98 ± 14.77 | 128.5 ± 15.3 | < 0.0001 |
DBP (mmHg) | 80.31 ± 10.31 | 78.36 ± 9.68 | 77.3 ± 9.48 | 75.73 ± 9.57 | < 0.0001 |
DM medication | None | 677037 (100) | 489945 (100) | 605818 (100) | < 0.0001 |
OHA ≥ 3 | None | 122456 (18.09) | 166263 (33.94) | 296615 (48.96) | < 0.0001 |
Metformin | None | 621307 (91.77) | 443228 (90.46) | 540323 (89.19) | < 0.0001 |
SGLT-2 inhibitor | None | 26509 (3.92) | 16904 (3.45) | 22732 (3.75) | < 0.0001 |
BMI (kg/m2) | 25.59 ± 3.71 | 25.77 ± 3.61 | 25.29 ± 3.4 | 24.57 ± 3.23 | < 0.0001 |
BMI-level | < 0.0001 | ||||
< 18.5 | 10909 (1.51) | 6977 (1.03) | 5778 (1.18) | 10082 (1.66) | |
18.5-23 | 154876 (21.44) | 132903 (19.63) | 113133 (23.09) | 180810 (29.85) | |
23-25 | 163960 (22.7) | 156199 (23.07) | 122022 (24.91) | 160905 (26.56) | |
25-30 | 311871 (43.18) | 302572 (44.69) | 206796 (42.21) | 220089 (36.33) | |
≥ 30 | 80615 (11.16) | 78386 (11.58) | 42216 (8.62) | 33932 (5.6) | |
WC (cm) | 22.87 ± 3.19 | 24.27 ± 3.24 | 25.18 ± 3.34 | 25.71 ± 4.75 | < 0.0001 |
WC level (M/F) | < 0.0001 | ||||
< 80/75 | 119073 (16.49) | 84582 (12.49) | 65915 (13.45) | 95204 (15.71) | |
< 85/80 | 147428 (20.41) | 125227 (18.5) | 94982 (19.39) | 126214 (20.83) | |
< 90/85 | 173565 (24.03) | 164474 (24.29) | 120917 (24.68) | 150216 (24.8) | |
< 95/90 | 136216 (18.86) | 138283 (20.42) | 99184 (20.24) | 116400 (19.21) | |
< 100/95 | 79117 (10.95) | 87794 (12.97) | 60251 (12.3) | 67084 (11.07) | |
≥ 100/95 | 66832 (9.25) | 76677 (11.33) | 48696 (9.94) | 50700 (8.37) | |
FBS (mg/dL) | 151.55 ± 39.14 | 137.74 ± 46.25 | 140.25 ± 45.05 | 147.38 ± 51.13 | < 0.0001 |
TC (mg/dL) | 207.12 ± 41.98 | 184.24 ± 43.26 | 174.27 ± 39.29 | 169.26 ± 38.74 | < 0.0001 |
HDL-C (mg/dL) | 52.62 ± 16.28 | 50.62 ± 14.18 | 50.34 ± 13.73 | 49.88 ± 13.92 | < 0.0001 |
LDL-C (mg/dL) | 119.45 ± 38.36 | 102.28 ± 38.38 | 94.54 ± 35.01 | 91.57 ± 34.23 | < 0.0001 |
eGFR | 93.6 ± 59.94 | 91.59 ± 51.48 | 88.39 ± 49.71 | 83 ± 47.49 | < 0.0001 |
TG (mg/dL)4 | 156.25 (156.03-156.46) | 139.11 (138.93-139.29) | 130.23 (130.03-130.42) | 122.61 (122.44-122.77) | < 0.0001 |
- Citation: Bae EH, Lim SY, Kim BS, Han KD, Suh SH, Choi HS, Kim CS, Ma SK, Kim SW. Exercise intensity and the risk of end-stage renal disease in diabetes: A nationwide population-based study. World J Diabetes 2025; 16(7): 108344
- URL: https://www.wjgnet.com/1948-9358/full/v16/i7/108344.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i7.108344